Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 1 - 2 of about 2   

Articles published

NVO 44.29 -0.06 (-0.14%)
price chart
Novo Nordisk: Encouraging Pipeline News
Novo Nordisk A/S (NYSE:NVO) has been on an uptrend since July 2012, thanks in large part to strong second quarter results. However, this Denmark-based ... portfolio of diabetes products. ADRs of Novo Nordisk hit a 52-week high of $169.74 on October 19.
Novo Nordisk A/S - Aggressive Growth  NASDAQ
Related articles »  
Post-Market News: AIG, UPS, GE, GS, SBUX, BAC, CAT, YHOO, OZM, CMG, KR
Danish drug maker Novo Nordisk A/S (ADR) (NYSE:NVO) (CPH:NOVO-B) said its long-acting insulin Tresiba has been recommended for approval by advisory panel to the European Medicines Agency.
Related articles »